AstraZeneca sales rise 10% in a year dominated by the coronavirus

AstraZeneca has featured prominently in 2020 because of its coronavirus jab, although it has said will not profit from the vaccine during the pandemic.

from Health and Science https://ift.tt/3d527Qe
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH